| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-49. doi:10.3322/caac.21660
|
| [2] |
Llovet JM, Kelley RK, Villanueva A, et al. Author correction: hepatocellular carcinoma[J]. Nat Rev Dis Primers, 2024, 10(1): 10. doi:10.1038/s41572-024-00500-6
|
| [3] |
Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(10): 589-604. doi:10.1038/s41575-019-0186-y
|
| [4] |
Kapila YL. Oral health's inextricable connection to systemic health: special populations bring to bear multimodal relationships and factors connecting periodontal disease to systemic diseases and conditions [J]. Periodontol 2000, 2021, 87(1): 11-6. doi:10.1111/prd.12398
|
| [5] |
Stasiewicz M, Karpinski TM. The oral microbiota and its role in carcinogenesis [J]. Semin Cancer Biol, 2022, 86(Pt 3): 633-42. doi:10.1016/j.semcancer.2021.11.002
|
| [6] |
Feng K, Ren F, Wang X. Association between oral microbiome and seven types of cancers in East Asian population: a two-sample Mendelian randomization analysis[J]. Front Mol Biosci, 2023, 10: 1327893. doi:10.3389/fmolb.2023.1327893
|
| [7] |
Albuquerque-Souza E, Sahingur SE. Periodontitis, chronic liver diseases, and the emerging oral-gut-liver axis[J]. Periodontol 2000, 2022, 89(1): 125-41. doi:10.1111/prd.12427
|
| [8] |
Furusho H, Miyauchi M, Hyogo H, et al. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice [J]. J Gastroenterol, 2013, 48(11): 1259-70. doi:10.1007/s00535-012-0738-1
|
| [9] |
Yang B, Petrick JL, Abnet CC, et al. Tooth loss and liver cancer incidence in a Finnish cohort[J]. Cancer Causes Control, 2017, 28(8): 899-904. doi:10.1007/s10552-017-0906-y
|
| [10] |
Teles FRF, Alawi F, Castilho RM, et al. Association or causation? Exploring the oral microbiome and cancer links[J]. J Dent Res, 2020, 99(13): 1411-24. doi:10.1177/0022034520945242
|
| [11] |
Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review [J]. Res Synth Methods, 2019, 10(4): 486-96. doi:10.1002/jrsm.1346
|
| [12] |
Liu X, Tong X, Zhu J, et al. Metagenome-genome-wide association studies reveal human genetic impact on the oral microbiome[J]. Cell Discov, 2021, 7(1): 117. doi:10.1038/s41421-021-00356-0
|
| [13] |
Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method[J]. Eur J Epidemiol, 2017, 32(5): 377-89. doi:10.1007/s10654-017-0255-x
|
| [14] |
Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses[J]. Am J Hum Genet, 2007, 81(3): 559-75. doi:10.1086/519795
|
| [15] |
Burgess S, Davey Smith G, Davies NM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023 [J]. Wellcome Open Res, 2019, 4: 186. doi:10.12688/wellcomeopenres.15555.1
|
| [16] |
Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies[J]. Hum Mol Genet, 2014, 23(R1): R89-98. doi:10.1093/hmg/ddu328
|
| [17] |
Coussens LM, Werb Z. Inflammation and cancer[J]. Nature, 2002, 420(6917): 860-7. doi:10.1038/nature01322
|
| [18] |
Shrihari TG, Vasudevan V, Manjunath V, et al. Potential co-relation between chronic periodontitis and cancer-an emerging concept[J]. Gulf J Oncolog, 2016, 1(20): 20-4.
|
| [19] |
Munn LL. Cancer and inflammation[J]. Wiley Interdiscip Rev Syst Biol Med, 2017, 9(2).
|
| [20] |
Gnocchi D, Bruscalupi G. Circadian rhythms and hormonal homeostasis: pathophysiological implications[J]. Biology (Basel), 2017, 6(1). doi:10.3390/biology6010010
|
| [21] |
Bolshette N, Ibrahim H, Reinke H, et al. Circadian regulation of liver function: from molecular mechanisms to disease pathophysiology[J]. Nat Rev Gastroenterol Hepatol, 2023, 20(11): 695-707. doi:10.1038/s41575-023-00792-1
|
| [22] |
Gnocchi D, Custodero C, Sabba C, et al. Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology[J]. J Mol Med (Berl), 2019, 97(6): 741-59. doi:10.1007/s00109-019-01780-2
|
| [23] |
Chellappa SL, Engen PA, Naqib A, et al. Proof-of-principle demonstration of endogenous circadian system and circadian misalignment effects on human oral microbiota[J]. FASEB J, 2022, 36(1): e22043. doi:10.1096/fj.202101153r
|
| [24] |
Sarkar A, Kuehl MN, Alman AC, et al. Linking the oral microbiome and salivary cytokine abundance to circadian oscillations[J]. Sci Rep, 2021, 11(1): 2658. doi:10.1038/s41598-021-81420-3
|
| [25] |
Zhang Y, Li Y, Barber AF, et al. The microbiome stabilizes circadian rhythms in the gut [J]. Proc Natl Acad Sci USA, 2023, 120(5): e2217532120. doi:10.1073/pnas.2217532120
|
| [26] |
Chambers L, Seidler K, Barrow M. Circadian misalignment in obesity: the role for time-restricted feeding[J]. Clin Nutr ESPEN, 2023, 57: 430-47. doi:10.1016/j.clnesp.2023.07.086
|
| [27] |
Fan X, Song Z, Qin W, et al. Potential common molecular mechanisms between periodontitis and hepatocellular carcinoma: a bioinformatic analysis and validation[J]. Cancer Genomics Proteomics, 2023, 20(6): 602-16. doi:10.21873/cgp.20409
|
| [28] |
Sasaki N, Katagiri S, Komazaki R, et al. Endotoxemia by Porphyromonas gingivalis injection aggravates non-alcoholic fatty liver disease, disrupts glucose/lipid metabolism, and alters gut microbiota in mice [J]. Front Microbiol, 2018, 9: 2470. doi:10.3389/fmicb.2018.02470
|
| [29] |
Nagasaki A, Sakamoto S, Chea C, et al. Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activation [J]. Sci Rep, 2020, 10(1): 4134. doi:10.1038/s41598-020-60904-8
|
| [30] |
Seyama M, Yoshida K, Yoshida K, et al. Outer membrane vesicles of Porphyromonas gingivalis attenuate insulin sensitivity by delivering gingipains to the liver[J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(6): 165731. doi:10.1016/j.bbadis.2020.165731
|
| [31] |
Varela-Lopez A, Bullon P, Ramirez-Tortosa CL, et al. A diet rich in saturated fat and cholesterol aggravates the effect of bacterial lipopolysaccharide on alveolar bone loss in a rabbit model of periodontal disease[J]. Nutrients, 2020, 12(5). doi:10.3390/nu12051405
|
| [32] |
Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases [J]. Lancet, 2005, 366(9499): 1809-20. doi:10.1016/s0140-6736(05)67728-8
|
| [33] |
Nakajima M, Arimatsu K, Kato T, et al. Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver [J]. PLoS One, 2015, 10(7): e0134234. doi:10.1371/journal.pone.0134234
|
| [34] |
Schwabe RF, Jobin C. The microbiome and cancer[J]. Nat Rev Cancer, 2013, 13(11): 800-12. doi:10.1038/nrc3610
|
| [35] |
Rams TE, Hawley CE, Whitaker EJ, et al. Centipeda periodontii in human periodontitis [J]. Odontology, 2015, 103(3): 286-91. doi:10.1007/s10266-014-0166-1
|
| [36] |
Huo T, Huang X, Liao J, et al. The bidirectional effects and mechanisms of the oral and gut microbiomes: a narrative review [J]. Front Immunol, 2026, 17: 1697413. doi:10.3389/fimmu.2026.1697413
|
| [37] |
Kim JG, Zhang A, Rauseo AM, et al. The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma [J]. Allergy, 2022, 77(12): 3676-9. doi:10.1111/all.15438
|
| [38] |
Xie Y, Xie F, Zhou X, et al. Microbiota in tumors: from understanding to application[J]. Adv Sci (Weinh), 2022, 9(21): e2200470. doi:10.1002/advs.202200470
|
| [39] |
Guo Z, Yao Z, Chen X, et al. Mechanistic roles and intervention strategies involving gut microbiota, amino acid metabolism, and the tumor immune microenvironment in MAFLD-HCC progression[J]. Clin Exp Med, 2025, 26(1): 31. doi:10.1007/s10238-025-01906-6
|
| [40] |
Liu Y, Zhou Q, Ye F, et al. Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization [J]. Neoplasia, 2023, 43: 100928. doi:10.1016/j.neo.2023.100928
|
| [41] |
Lei L, Yu J, Zhang B, et al. Systematic profiling reveals hepatic immune and metabolic dysregulation in DNASE1L3-deficient mice [J]. iScience, 2025, 28(12): 114198. doi:10.1016/j.isci.2025.114198
|